Latest Australian Securities Exchange News

Dropsuite Limited’s shares are suspended from ASX trading following Federal Court approval of its acquisition by NinjaOne Australia, marking a pivotal step in the company’s transition.

Dropsuite Limited’s acquisition by NinjaOne Australia has been legally approved, triggering a suspension of trading on the ASX and a $5.90 per share cash payout to shareholders.

Mayne Pharma has addressed a sharp share price decline following the public release of an FDA Untitled Letter, confirming no undisclosed material information and reaffirming compliance with ASX rules.

Highfield Resources Limited has had its ASX trading suspension lifted immediately following a key announcement on its funding arrangements, signaling renewed market confidence.

Mount Burgess Mining NL has voluntarily suspended trading of its shares on the ASX pending a court ruling on the validity of a recent cleansing notice tied to new share issuance.

Nimy Resources has clarified that no undisclosed information explains its recent share price jump, pointing instead to ongoing drilling and positive media coverage about a gallium discovery.

A significant shareholder has lodged an application with the Takeovers Panel challenging Pact Group Holdings’ proposed delisting from the ASX, alleging misleading reasons and coercion of minority investors.

Holista Colltech Limited has responded to an ASX price query regarding recent unusual trading activity, confirming no undisclosed material information exists to explain the surge.

Raptis Group Limited has voluntarily suspended trading on the ASX as it prepares to announce a significant share placement and entitlement offer, signaling a pivotal moment for the company’s capital structure.

Botanix Pharmaceuticals has clarified that recent share price movements are linked to a rumored US executive order on drug pricing, confirming no undisclosed material information. The company reassures investors of compliance with ASX disclosure rules amid market speculation.

Trading in Black Rock Mining Limited shares has resumed following the lifting of a suspension tied to regulatory correspondence from Tanzania about its Mahenge Graphite Project licence.

Mayne Pharma Group has acknowledged a delayed filing of a director's interest notice due to administrative oversight and is taking steps to reinforce compliance with ASX disclosure rules.